Achilles Therapeutics plc
NASDAQ:ACHL
1.045 (USD) • At close November 7, 2024
Overzicht | Financiële gegevens
Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) USD.
2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Omzet
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.58 | 0 | 0 | 0 | 0.18 | 0 | 0 |
Kosten van de omzet
| 1.178 | 1.179 | 1.158 | 1.197 | 1.304 | 0 | 0.837 | 0.892 | 0.892 | 1.047 | 0.838 | 0.896 | 0.798 | 0 | 0 | 0.29 | 0 | 0 | 0 | 0.09 | 0.045 | 0.045 |
Brutowinst
| -1.178 | -1.179 | -1.158 | -1.197 | -1.304 | 0 | -0.837 | -0.892 | -0.892 | -1.047 | -0.838 | -0.896 | -0.798 | 0 | 0 | 0.29 | 0 | 0 | 0 | 0.09 | -0.045 | -0.045 |
Brutowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.5 | 0 | 0 | 0 | 0.5 | 0 | 0 |
Onderzoek- en ontwikkelingskosten
| 13.65 | 10.134 | 16.03 | 14.712 | 13.774 | 13.868 | 18.876 | 10.597 | 14.776 | 13.014 | 11.807 | 10.697 | 10.844 | 8.876 | 8.961 | 5.291 | 4.547 | 3.83 | 2.746 | 1.232 | 2.547 | 2.547 |
Algemene en administratieve kosten
| 4.164 | 4.159 | 3.622 | 4.384 | 4.318 | 4.685 | 3.958 | 5.437 | 5.77 | 5.955 | 6.653 | 5.041 | 5.445 | 4.832 | 3.958 | 3.009 | 2.395 | 1.736 | 1.689 | 1.011 | 1.002 | 1.002 |
Verkoop- en marketingkosten
| -1.174 | -1.182 | -1.126 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Verkoop-, algemene en administratieve kosten
| 2.99 | 2.977 | 2.496 | 4.384 | 4.318 | 4.685 | 3.958 | 5.437 | 5.77 | 5.955 | 6.653 | 5.041 | 5.445 | 4.832 | 3.958 | 3.009 | 2.395 | 1.736 | 1.689 | 1.011 | 1.002 | 1.002 |
Overige kosten
| 1.427 | 2.002 | 1.389 | 2.389 | 1.212 | 1.091 | -1.181 | 3.599 | 3.271 | 1.629 | 0.226 | 2.806 | 0.146 | -0.045 | 0.002 | 0.09 | 0.087 | 0.352 | -16.731 | -6.941 | -6.941 | -6.941 |
Bedrijfskosten
| 16.641 | 13.112 | 18.526 | 19.096 | 18.092 | 18.553 | 22.834 | 16.034 | 20.546 | 18.969 | 18.46 | 15.738 | 16.289 | 13.708 | 12.919 | 8.3 | 6.942 | 5.566 | 4.558 | 2.438 | 3.497 | 3.497 |
Bedrijfsresultaat
| -17.819 | -14.291 | -19.684 | -19.096 | -18.092 | -18.553 | -22.834 | -16.034 | -20.546 | -18.969 | -18.46 | -15.738 | -16.289 | -13.708 | -12.919 | -8.3 | -6.942 | -5.566 | -4.435 | -2.243 | -3.549 | -3.549 |
Bedrijfsresultaat ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.31 | 0 | 0 | 0 | -12.461 | 0 | 0 |
Totaal overige inkomsten en kosten netto
| 1.429 | 2.001 | 1.401 | 2.389 | 1.212 | 1.091 | -1.181 | 3.599 | 3.271 | 1.629 | 0.226 | 2.806 | 0.146 | -0.045 | 0.002 | 0.09 | 0.087 | 0.352 | -0.123 | -0.105 | 0.007 | 0.007 |
Inkomen voor belasting
| -16.39 | -12.29 | -18.283 | -16.707 | -16.88 | -17.462 | -24.015 | -12.435 | -17.275 | -17.34 | -18.234 | -12.932 | -16.143 | -13.753 | -12.917 | -8.21 | -6.855 | -5.214 | -4.558 | -2.348 | -3.542 | -3.542 |
Inkomen voor belasting ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.155 | 0 | 0 | 0 | -13.044 | 0 | 0 |
Belastingkosten
| 0.008 | -0.023 | 0.509 | -0.024 | -0.034 | 0.044 | 0.041 | 0.041 | 0.014 | 0.015 | -0.004 | 0.016 | 0.013 | 0.012 | 0.003 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 |
Nettowinst
| -16.398 | -12.267 | -18.792 | -16.683 | -16.846 | -17.506 | -24.056 | -12.476 | -17.289 | -17.355 | -18.23 | -12.948 | -16.156 | -13.765 | -12.92 | -8.21 | -6.855 | -5.214 | -4.558 | -2.348 | -3.542 | -3.542 |
Nettowinstmarge
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.155 | 0 | 0 | 0 | -13.044 | 0 | 0 |
WPA (Winst Per Aandeel)
| -0.41 | -0.3 | -0.47 | -0.42 | -0.42 | -0.44 | -0.61 | -0.32 | -0.44 | -0.45 | -0.64 | -0.34 | -0.45 | -8.38 | -0.32 | -5 | -4.17 | -3.18 | -6.3 | -3.66 | -5.89 | -5.89 |
Verwaterde WPA
| -0.41 | -0.3 | -0.47 | -0.42 | -0.42 | -0.44 | -0.61 | -0.32 | -0.44 | -0.45 | -0.64 | -0.34 | -0.45 | -8.38 | -0.32 | -5 | -4.17 | -3.18 | -6.29 | -3.66 | -5.89 | -5.89 |
EBITDA
| -16.641 | -13.112 | -18.526 | -19.096 | -18.092 | -18.553 | -22.834 | -16.034 | -19.63 | -17.916 | -17.623 | -14.906 | -15.459 | -12.919 | -12.52 | -8.3 | -6.942 | -5.469 | -4.336 | -2.162 | -3.488 | -3.488 |
EBITDA ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -14.31 | 0 | 0 | 0 | -12.011 | 0 | 0 |